This meeting took place in the past. For a complete list of the meetings for the upcoming/current season, see our meeting list or click on related meetings tab below to check for related meeting(s).
Web Desc
HIV Pathogenesis
joint with HIV Vaccines: Progress and Prospects
Organizer(s): Steven M. Wolinsky, John P. Moore and Bette T. Korber
Date: March 27 - April 01, 2008
Location: Fairmont Banff Springs, Banff, AB, Canada
Part of the Keystone Symposia Global Health Series, Supported by the Bill & Melinda Gates Foundation
Summary of Meeting:
Elucidating the molecular mechanisms of HIV infection is essential for the design and development of an effective vaccine and the next generation of antiviral agents. This Keystone Symposia meeting will focus on (1) our understanding of HIV proteins and their functions, (2) host factors used to aid in viral replication, (3) viral genetic diversity and adaptation, and (4) the central role of the destruction of CD4+ T cells in lymphoid tissue to the pathogenesis. The pathogenic mechanisms of HIV infection from transmission through clinical latency, including the means used by the virus to establish infection and propagate in target cells and evade the innate and adaptive host defense mechanisms will be examined. Scientists from diverse disciplines will be brought together with the objective of devising vaccines and other biology-based ways to prevent transmission and progression to AIDS. The meeting will promote further insights into the dynamic interplay between the virus, the host, and its immune response.
Global Health Travel Award Deadline: November 12 2007
Scholarship Deadline: November 28 2007
Discounted Abstract Deadline: November 28 2007
Abstract Deadline: December 28 2007
Discounted Registration Deadline: January 28 2008
We gratefully acknowledge additional support for this conference from:
Bill & Melinda Gates FoundationBoehringer Ingelheim (Canada) Ltd.Merck Research LaboratoriesOffice of AIDS Research, NIH
We gratefully acknowledge additional in-kind support for this conference from those foregoing speaker expense reimbursements:

Merck & Co., Inc.
We gratefully acknowledge the generous grant for this conference provided by:

National Institute of Allergy and Infectious Diseases (NIAID)
Grant No. 5R13AI068352-03
We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:

Click here to view more of these organizations
Special thanks to the following for their support of Keystone Symposia initiatives to increase participation at this meeting by scientists from underrepresented backgrounds:

Click here to view more of these organizations

No content found

No content found

No content found

No content found